IN8bio, Inc.
INAB
$0.1449
$0.01219.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.90% | 13.07% | 17.88% | -0.78% | -12.69% |
| Total Depreciation and Amortization | -4.70% | 1.74% | 9.35% | -0.16% | 0.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.73% | -54.39% | 54.48% | -5.56% | -0.96% |
| Change in Net Operating Assets | 53.39% | 139.70% | -307.07% | 159.89% | -241.43% |
| Cash from Operations | 22.49% | 34.09% | -0.33% | 23.08% | -63.28% |
| Capital Expenditure | -- | -- | 100.00% | -16.90% | 1.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -16.90% | 1.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.74% | -2.82% | -22.41% | 7.45% | -8.67% |
| Issuance of Common Stock | -63.31% | 3,784.08% | -91.87% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -- | 100.00% | -- |
| Cash from Financing | -65.20% | 10,754.29% | -103.11% | 1,319.86% | -102.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.18% | 214.64% | -122.40% | 66.19% | -198.07% |